tezosentan has been researched along with Cardiac Output, Low in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Aneman, A; Burgener, D; Hadengue, A; Laesser, M; Strasser, S; Treggiari, MM | 1 |
Aneman, A; Burgener, D; Hadengue, A; Jolliet, P; Laesser, M; Oi, Y; Strasser, S; Treggiari-Venzi, M | 1 |
2 other study(ies) available for tezosentan and Cardiac Output, Low
Article | Year |
---|---|
Tezosentan normalizes hepatomesenteric perfusion in a porcine model of cardiac tamponade.
Topics: Animals; Carbon Dioxide; Cardiac Output, Low; Cardiac Tamponade; Drug Evaluation, Preclinical; Endothelin Receptor Antagonists; Endothelin-1; Female; Lactates; Liver Circulation; Male; Models, Animal; Oxygen; Oxygen Consumption; Pyridines; Splanchnic Circulation; Sus scrofa; Tetrazoles; Vascular Resistance; Vasoconstriction | 2009 |
Endothelin-1 blockade corrects mesenteric hypoperfusion in a porcine low cardiac output model.
Topics: Animals; Blood Gas Analysis; Cardiac Output, Low; Endothelin Receptor Antagonists; Endothelin-1; Female; Hemodynamics; Hydrogen-Ion Concentration; Male; Oximetry; Perfusion; Pyridines; Splanchnic Circulation; Swine; Tetrazoles; Vasoconstriction; Vasodilator Agents | 2001 |